Shinto E, Oki E, Shimokawa M, Yamaguchi S, et al. Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients. Ann Surg Oncol 2023 May 8. doi: 10.1245/s10434-023-13594.
PMID: 37154970